Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Europe’s biggest insurer turns away from Euro sovereign bonds - report

Friday, September 28, 2012

amb
Michael Diekmann
From Benedicte Gravrand, Opalesque Geneva, and Florian Guldner, Opalesque Munich – Allianz, Europe’s biggest insurer and one of its biggest investors, wants to invest Eur1.65bn ($2.1bn) but is changing its strategy. CEO Michael Diekmann is not interested in Euro sovereign bonds anymore, he tells German daily Handelsblatt.

He said during an interview with Handelsblatt: "we are trying to avoid government bonds in our new investments."

He adds that German bunds would not be attractive because their yield is below inflation level. And in other European countries, risk has increased because of the debt restructuring in Greece.

"This is why all investors go out of European sovereign bonds and instead invest in emerging economies, in corporate bonds, in infrastructure and real estate," Diekmann explains. Allianz is planning to diversify further. Some of the investments that are attractive to insurance companies, which are long term investors, include renewable energy and infrastructure. Allianz also wants to invest in power grids because in Germany the energy regulator regulates prices; and this gives investors some security, he says.

He believes he sovereign debt crisis in Europe cannot be solved through economic growth. According to his calculations, Germany would have to reach a 4% inflation level and a 4% GDP growth to reduce its own debt, which is not realistic. The only solution, he states, would be in government reducing its expendit......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its